by PierianDx, on February 26, 2019
Genomic tests that use next generation sequencing (NGS) technology are on the rise, and there’s a growing trend for hospitals to insource these tests to improve turnaround time and reduce costs. However, these tests can be challenging to implement. Challenges include lack of bioinformatics expertise, the cost and expense of deploying a new test, and reimbursement, to name a few.
Read Storyby PierianDx, on February 25, 2019
In just under 15 years, next generation sequencing (NGS) has evolved from a technology that only an exclusive few research laboratories had access to, to one in use by nearly 300 clinical laboratories worldwide.1,2
Read Storyby PierianDx, on February 7, 2019
At PierianDx, we are well-versed in helping healthcare organizations implement clinical next generation sequencing (NGS) testing programs. But beyond implementation of genomic testing programs at individual institutions, what must happen to make this technology more readily available to all?
Read Story
6 City Place
Creve Coeur, MO 63141
314-628-0035